Oberland Capital Management
New York City, New Yorkoberlandcapital.com
Overview
Oberland Capital Management is a private investment firm that provides structured financing solutions, including royalty monetizations and asset-backed credit facilities, to companies across the global healthcare industry.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ImmunityBio | Mar 2026 | Post-IPO Financing | Lead |
| Primmune Therapeutics | Jan 2026 | Series B | Co-investor |
| Humacyte | May 2023 | Debt | Lead |
| Primmune Therapeutics | Jan 2021 | Series A | Co-investor |
| Primmune Therapeutics | Oct 2020 | Series A | Co-investor |
Key People
James James
Managing Director, Business Development and Investor Relations
Cecilia Gonzalo
Partner
Sarah Drew Siber
Partner
William Clifford
Partner
Sean Fillion
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
